So based on past FDA decisions, this will be approved next week then ? lol
On a serious note though, one wonders if this will bode well for Rexlemestrocel-L ? At least we know there are no safety concerns with Rexlemestrocel-L so it is in front already, not to mention the great results achieved in the DREAM-HF phase 3 trial
Ann: Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE, page-298
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.005(0.54%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 91.5¢ | $1.473M | 1.596M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32370 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 60258 | 5 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |